![Margaret Dalesandro](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Margaret Dalesandro
Founder at
Brecon Pharma Consulting LLC
Profile
Margaret R.
Dalesandro is the founder of Brecon Pharma Consulting LLC, founded in 2012, serving as President.
Current jobs include Director at Emerald Health Bioceuticals, Inc. since 2020 and Independent Director at Ambrx Biopharma Cayman, Inc. since 2023.
Former jobs include Director-Immunobiology & Diagnostic Research at Centocor, Inc. from 1989 to 1998; Business Director-Integrative Pharmacology at Corning, Inc. from 2009 to 2012; Independent Director at OncoSec Medical, Inc. from 2019 to 2020; Executive Director-Project & Portfolio Management at GSK Plc from 2000 to 2002; Independent Director at Ambrx Biopharma Cayman, Inc. from 2023 to 2024; Independent Director at Skye Bioscience, Inc. from 2020 to 2024; Independent Director at Seelos Therapeutics, Inc. from 2021 to 2024; and VP-Project, Portfolio & Alliance Management at ImClone LLC from 2002 to 2009.
Education includes graduate and doctorate degrees from Bryn Mawr College and an undergraduate degree from Rosemont College.
Margaret Dalesandro active positions
| Companies | Position | Start |
|---|---|---|
Brecon Pharma Consulting LLC | Founder | 2012-08-31 |
Emerald Health Bioceuticals, Inc.
 Emerald Health Bioceuticals, Inc. BiotechnologyHealth Technology Provides research and development of phytocannabinoids and nutritional supplements for support of human endocannabinoid health | Director/Board Member | 2020-01-31 |
Ambrx Biopharma, Inc.
 Ambrx Biopharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biologics company | Director/Board Member | 2023-08-31 |
Former positions of Margaret Dalesandro
| Companies | Position | End |
|---|---|---|
| SEELOS THERAPEUTICS, INC. | Director/Board Member | 2024-10-15 |
| SKYE BIOSCIENCE, INC. | Director/Board Member | 2024-07-31 |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biologics company | Director/Board Member | 2024-03-06 |
| ONCOSEC MEDICAL INCORPORATED | Chief Executive Officer | 2021-12-12 |
| CORNING INCORPORATED | Corporate Officer/Principal | 2011-12-31 |
Training of Margaret Dalesandro
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
64
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Health Technology |
Corning, Inc.
 Corning, Inc. Electronic ComponentsElectronic Technology Manufactures specialty glass and ceramics | Electronic Technology |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
OncoSec Medical, Inc.
 OncoSec Medical, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel immunotherapeutic products for immuno-oncology treatment | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Bryn Mawr College
 Bryn Mawr College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rosemont College
 Rosemont College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Skye Bioscience, Inc.
 Skye Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets cannabinoid derivatives to treat ophthalmic disorders | Health Technology |
Emerald Health Bioceuticals, Inc.
Emerald Health Bioceuticals, Inc. BiotechnologyHealth Technology Provides research and development of phytocannabinoids and nutritional supplements for support of human endocannabinoid health | Health Technology |
Seelos Therapeutics, Inc.
 Seelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for neurological disorders and rare diseases using pipeline targeting CNS conditions | Health Technology |
Brecon Pharma Consulting LLC | |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biologics company | Health Technology |
- Stock Market
- Insiders
- Margaret Dalesandro
